InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

- Current share price for NSB : $0.059

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Appendix 4G 23 Sep 2021 4:45PM $0.440 $0.059 fallen by 86.59%
$23 Corporate Governance Statement 23 Sep 2021 4:45PM $0.440 $0.059 fallen by 86.59%
$23 Date of AGM & Closing Date for Director Nominations 21 Sep 2021 4:21PM $0.445 $0.059 fallen by 86.74%
$23 Broker Briefing Investor Webinar 8 Sep 2021 8:21AM $0.360 $0.059 fallen by 83.61%
$23 Company Presentation 3 Sep 2021 12:28PM $0.335 $0.059 fallen by 82.39%
$23 Investor Webinar 3 Sep 2021 12:27PM $0.335 $0.059 fallen by 82.39%
$23 NSB Receives R&D Advance & Overseas Finding 3 Sep 2021 9:05AM $0.315 $0.059 fallen by 81.27%
$23 Positive Results in Multiple Sclerosis Study 31 Aug 2021 8:05AM $0.330 $0.059 fallen by 82.12%
$23 2021 Annual Report and Appendix 4E 27 Aug 2021 1:33PM $0.320 $0.059 fallen by 81.56%
$23 NSB appoints International Scientific Advisors 24 Aug 2021 9:22AM $0.300 $0.059 fallen by 80.33%
$23 Results from Pulmonary Studies Clarification 20 Aug 2021 1:28PM $0.315 $0.059 fallen by 81.27%
$23 Trading Halt 19 Aug 2021 12:59PM $0.315 $0.059 fallen by 81.27%
$23 Pause in Trading 19 Aug 2021 12:13PM $0.315 $0.059 fallen by 81.27%
$23 Results from Pulmonary Studies 19 Aug 2021 8:11AM $0.290 $0.059 fallen by 79.66%
$23 Quarterly Update and Appendix 4C 30 Jul 2021 10:01AM $0.310 $0.059 fallen by 80.97%
$23 Change of Director's Interest Notice 13 Jul 2021 2:12PM $0.320 $0.059 fallen by 81.56%
$23 Successful completion of pivotal ocular safety study 1 Jul 2021 9:47AM $0.335 $0.059 fallen by 82.39%
$23 Trading Halt 30 Jun 2021 10:26AM $0.335 $0.059 fallen by 82.39%
$23 Pause in Trading 30 Jun 2021 10:04AM $0.335 $0.059 fallen by 82.39%
$23 Initial Director's Interest Notice 28 Jun 2021 4:58PM $0.340 $0.059 fallen by 82.65%
$23 Gold Coast Investment Showcase Presentation 23 Jun 2021 12:50PM $0.350 $0.059 fallen by 83.14%
$23 NSB partners with Linear Research for Phase I Clinical Study 23 Jun 2021 8:18AM $0.360 $0.059 fallen by 83.61%
$23 Proposed issue of securities - NSB 22 Jun 2021 4:31PM $0.360 $0.059 fallen by 83.61%
$23 Appointment of Non-executive Chairman 22 Jun 2021 8:18AM $0.310 $0.059 fallen by 80.97%
$23 R&D Tax Rebate Received 31 May 2021 11:30AM $0.320 $0.059 fallen by 81.56%

201 - 225 of 409 results

Page 9 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.